Brief: Bioventus reports Q4 sales USD 125.8 million
31/03/2023 12:35
Mar 31 (Reuters) - Bioventus Q4 adjusted operating income USD 11.8 million. * Q4 adjusted gross profit USD 89.6 million * Q4 net income USD -44.9 million * Q4 adjusted EBITDA USD 15.2 million * Q4 adjusted EPS USD -0.06 * Q4 sales USD 125.8 million
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks